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This study reports the detection of co-infection by multiple CPV variants and the high genetic complexity of a CPV-2 strain detected in a
domestic cat. The CPV variants selected by cloning the VP2 gene were sequenced, and genetic diversity and selection pressure were investigated.
Comparison of the nucleotide sequences has evidenced 10 different viral populations, and, in the same animal, more CPV variants coexist. Our
analysis excludes the possibility that the recombination events took place during infection and that negative selection acted on the VP2 gene.
These findings confirm that CPV-2 shows high genetic heterogeneity resembling the quasispecies found in RNA viruses.
© 2006 Elsevier Inc. All rights reserved.Keywords: Canine parvovirus; Cat; Quasispecies; Selection pressureIntroduction
Canine parvovirus type 2 (CPV-2) is a recent new pathogenic
agent which causes severe hemorrhagic gastroenteritis in dogs.
CPV-2 was first isolated from a dog in 1978 in the U.S. and
spread rapidly all over the world. Between 1979 and 1981, the
original type 2 was replaced by a new genetic and antigenic
variant, type 2a (CPV-2a), and then, between 1983 and 1984, it
was replaced by type 2b (CPV-2b) which differs from type 2a
by only a single epitope localized in residue 426 (Parrish et al.,
1991).
The new variants have gained the feline host range to cats
since they are able to infect both dogs and cats, whereas the
original CPV-2 does not replicate in cats (Truyen et al., 1996).
Recently, CPV-2a or 2b have been isolated from domestic cats
in Japan, Germany, the U.S., Taiwan, Vietnam and Italy (Truyen
et al., 1996; Ikeda et al., 2000; Battilani et al., in press). The
evolution of the canine parvovirus group continues. Recently, a
new antigenic change has been observed in CPV-2 strains⁎ Corresponding author. Dipartimento di Sanità Pubblica Veterinaria e
Patologia Animale, servizio MIPAV, Facoltà di Medicina Veterinaria, Alma
Mater Studiorum-Università di Bologna, Via Tolara di Sopra, 50, 40064-Ozzano
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doi:10.1016/j.virol.2006.06.002isolated from domestic dogs in Italy (Buonavoglia et al., 2001);
it was then also detected in Vietnam (Nakamura et al., 2004).
This new variant, also recently detected in cats (Battilani et al.,
in press), is characterized by the presence of glutamic acid in
residue 426 of the VP2 protein, the epitope which distinguishes
the 2a/2b variants, and this amino acid change causes an
antigenic difference detectable using monoclonal antibodies
(Nakamura et al., 2004) so the N/D426E mutant can be
considered a novel antigenic variant, tentatively named type 2c.
Additional antigenic variants which have emerged during recent
years have been detected among CPV-2a and CPV-2b, resulting
from single amino acid substitutions in the VP2 gene (Battilani
et al., 2002; Ikeda et al., 2000).
As a result of the species jump of CPV from dogs to cats,
several studies have been carried out in order to investigate
which CPV variants circulate among the feline population and
how CPV evolves in cats (Ikeda et al., 2000). Furthermore, the
potential pathogenicity of CPV in domestic cats is still obscure;
experimentally-caused infections suggested that CPV-2a/2b
viruses have a lower pathogenicity in infected cats and could
cause persistent infection, although the general condition of the
cats before infection determines the seriousness of the illness.
In the study described here, we report the detection of co-
infection by multiple CPV variants and the high genetic
complexity of a CPV-2 strain detected in a domestic cat. The
Ta
bl
e
1
V
ar
ia
bl
e
nu
cl
eo
tid
es
in
th
e
se
qu
en
ce
s
of
th
e
V
P
2
ge
ne
s
an
al
yz
ed
in
th
is
st
ud
y;
di
ff
er
in
g
nu
cl
eo
tid
es
ar
e
in
di
ca
te
d
by
a
le
tte
r;
th
e
nu
cl
eo
tid
es
id
en
tic
al
to
cl
on
e
1
ar
e
in
di
ca
te
d
as
da
sh
es
w
hi
le
th
e
nu
cl
eo
tid
es
di
ff
er
in
g
fr
om
cl
on
e
1
ar
e
w
ri
tte
n
N
t.
co
m
pl
et
e
ge
no
m
e
(2
95
5)
(3
09
9)
(3
17
2)
(3
21
1)
(3
51
3)
(3
53
3)
(3
53
4)
(3
66
2)
(3
68
0)
(3
74
6)
(3
76
7)
(3
97
5)
(3
98
3)
(4
06
2)
(4
06
4)
(4
10
4)
(4
38
8)
(4
34
8)
(4
47
1)
N
t.
V
P
2
ge
ne
16
9
31
3
38
6
42
5
72
7
74
7
74
8
87
6
89
4
96
0
98
1
11
89
11
97
12
76
12
78
13
18
13
80
15
62
16
85
C
lo
ne
1
A
A
C
A
T
C
G
T
A
A
A
A
A
A
T
A
G
C
T
C
lo
ne
2
G
−
T
−
−
T
−
C
−
−
−
G
G
−
−
−
A
T
−
C
lo
ne
3
G
−
T
G
−
T
−
−
−
−
−
−
−
−
−
−
A
T
−
C
lo
ne
4
G
−
T
−
C
T
−
−
−
−
−
−
−
−
−
−
A
T
−
C
lo
ne
5
G
−
T
−
−
T
−
−
−
−
−
−
−
G
A
−
A
T
−
C
lo
ne
6
G
−
T
−
−
T
−
−
−
−
−
−
−
−
−
G
A
T
−
C
lo
ne
7
G
−
T
−
−
T
A
−
−
G
−
−
−
−
−
−
A
T
−
C
lo
ne
9
G
−
T
−
−
T
−
−
G
−
G
−
−
−
−
−
A
T
−
C
lo
ne
10
G
−
T
−
−
T
−
−
−
−
−
−
−
−
−
−
A
T
−
C
lo
ne
11
G
G
T
−
−
T
−
−
−
−
−
−
−
−
−
−
A
T
−
C
lo
ne
12
G
−
T
−
−
T
−
−
−
−
−
−
−
−
−
−
A
T
C
C
lo
ne
13
G
−
T
−
−
T
−
−
−
−
−
−
−
−
−
−
A
T
−
C
lo
ne
14
G
−
T
−
−
T
−
−
−
−
−
−
−
−
−
−
A
T
−
C
lo
ne
15
G
−
T
−
−
T
−
−
−
−
−
−
−
−
−
−
A
T
−
V
P
2
R
57
→
G
I1
05
→
V
T
12
9
→
I
E
14
2
→
G
F
24
3
→
L
V
25
0
→
M
R
39
7
→
G
N
42
6
→
E
T
44
0
→
A
T
52
1
→
I
V
56
2
→
A
N
uc
le
ot
id
e
ch
an
ge
s
w
hi
ch
re
su
lt
in
am
in
o
ac
id
su
bs
tit
ut
io
ns
ar
e
in
di
ca
te
d
w
ith
th
e
re
si
du
e
po
si
tio
n
of
th
e
V
P
2
pr
ot
ei
n
an
d
de
du
ce
d
am
in
o
ac
id
ch
an
ge
s.
23Rapid CommunicationCPV variants selected by cloning the VP2 gene were
sequenced, and genetic diversity and selection pressure were
investigated. An extensive sequence diversity in the viral clones
analyzed was detected with 10 different viral populations,
differing in identity by 99.5 to 99.9%. Detailed analysis of the
amino acid sequences of the clones indicated that multiple CPV
variants were present at the same time in the infected animal.
These findings showed that CPV, despite being a single-
stranded DNA virus, has high genetic heterogeneity resembling
the quasispecies found in RNA viruses and multiple infection
with several virus types can occur in vivo.
Results
The nucleotide sequences of the VP2 gene inserted in the
recombinant clones were 1745 bp in length. Fourteen clones
were chosen for sequencing. Comparison of the nucleotide
sequences has evidenced 10 different viral populations; clones
10-13-14-15 are identical, while the remaining clones differ in
identity by 99.5 to 99.9%.
The deduced amino acid sequences are identical in clones
9-10-13-14-15, the other clones showed a sequence similarity
which varied from 99.3 to 99.8%. Several synonymous and
non-synonymous substitutions were detected by comparison of
the sequences clones. Nucleotide changes and the predicted
amino acid sequence substitutions are shown in Table 1.
Plotting the amino acid substitutions detected in the clones in
the 3D structure of CPV VP2 (PDB ID 4DPV), we observed
that the major part of the mutations is located in the less
accessible part of the VP2 and only three substitutions,
R397G, N/D426E, T440A, are located on the exposed surface
of VP2.
Analyzing the amino acid positions which distinguish the
antigenic types of CPV, it was seen that, in the same animal, two
CPV variants coexist: the prevalent antigenic type in the viral
population is 2a, but clone 5 belongs to the new variant N/
D426E.
Statistical analyses were used to test nucleotide diversity
within the group of 116_05 clones, and the results were
compared to the sequence data of Italian CPV-2 strains.
A total of 19 polymorphic sites were found scattered within
the sequence data of sample 116_05. At the amino acid level,
we found 12 polymorphic sites. Summaries of sample sequence
variability are presented in Table 2. Sequence variability within
Italian CPV-2 strains was greater than variability within the
116_05 clones, as was seen by analysis of the value of
parameters k and π. These results were explainable by the fact
that the sequence data of Italian CPV include different strains
isolated in a temporal fraction of 10 years; therefore, during this
time, natural selection produced different variants which have
generally reflected an elevated background mutation rate typical
of the carnivore parvovirus group (Shackelton et al., 2005). The
nucleotide diversity of non-synonymous sites π (a) was greater
for the clone population for Italian CPV, indicating a clear
prevalence of the number of non-synonymous mutations in
sample 116_05. In fact, in the clone population, there were 12
non-synonymous mutations out of a total of 19 mutations; in the
Table 2
Summaries of sample sequence variability
Sample S a π b π (s) c π (a) d θw e k f
116_05
(n = 14) g
19 0.00156 0.00248 0.00128 0.00342 2.714
SE 0.00036 SE 0.0000021
Italian CPV
(n = 19)
28 0.00295 0.00950 0.00099 0.00459 5.146
SE 0.00027 SE 0.00176
a S, number of variable sites.
b π, nucleotide diversity.
c π (s), nucleotide diversity of synonymous sites.
d π (a), nucleotide diversity of non-synonymous sites.
e θw, Watterson's estimator (per site).
f k, average number of nucleotide differences.
g n, sample size.
24 Rapid CommunicationItalian CPV data, there were 7 non-synonymous mutations out
of a total of 28 mutations. In the data of both sequences, the
parameter θwwas higher than nucleotide diversity π, suggesting
that there exists a deviation from the assumption θ = π which
takes place if there is no natural selection in a large population
of constant size. Summaries of sample sequence variability are
presented in Table 2. To evaluate the selection pressure which
acts on the VP2 gene, the ratio of synonymous (dS) and non-
synonymous substitutions (dN) per site was calculated for the
entire gene; the value of the dN/dS ratio was estimated as 0.40
for clones 116_05 and as 0.08 for Italian CPV data set,
indicating that the ratio dN/dS for the clones 116_05 is fivefold
higher than that for the Italian CPV. The difference between the
estimates of the dN/dS values for the two groups was
statistically significant as estimated by a t test (P < 0.05). The
higher dN/dS ratio for sample 116_05 suggests that the amino
acids encoded by the VP2 gene underwent substitutions at a
relatively accelerated rate during adaptation in the animal. For
this reason, a maximum likelihood approach was used for the
identification of sites under selection in the viral clones. All the
methods used in the Datamonkey web interface were run, and
comparative analysis integration was performed. The SLAC
method does not detect sites subject to negative or positive
selection, whereas FEL and REL analysis found 7 negatively
selected sites (codons 249, 292, 298, 320, 327, 399, 460). The
only REL analysis detected 11 positively selected sites when the
value of the Bayes factor was 50 (codons 57, 105, 129, 142,
243, 250, 397, 426, 440, 521, 562), providing strong evidence
for the hypothesis, but when the Bayes factor value was 100, no
selection was found at the sites. As Bayes methods are prone to
false positives above all when the data sets are small, as in our
case, we hypothesized that no positive selection was involved in
these sites (Kosakovsky Pond and Frost, 2005).
No potential recombination events were detected in the data
set of the viral clones.
Discussion
Recent findings pointed out the presence of genetic
instability among DNA viruses with higher mutation and
substitution rates for ssDNA as compared to dsDNA (López-
Bueno et al., 2006). Among the ssDNA viruses, the parvo-viruses of carnivores provide an important evolutionary model
to explain how the emergence of a new pathogen can take place
by multiple amino acid changes in the capsid protein. The high
substitution rates observed during the emergence and evolution
of the CPV were similar to those seen in rapidly evolving RNA
viruses. A high degree of genetic variability was also observed
for other autonomous parvoviruses such as the Aleutian mink
disease virus (AMDV) (Gottschalck et al., 1994) and the minute
virus of mice (MVM) (Rubio et al., 2005; Lopez-Bueno and
Mateu, 2003). Among the subgroups of feline parvoviruses,
FPV and CPV show a different evolution pattern in their
respective hosts. FPV is in evolutionary stasis in cats and it
evolves with a random genetic drift, while CPVevolves in dogs
with an high mutation rate much closer to that of RNA viruses,
with strong positive selection which acts on specific residues of
VP2, resulting in the emergence of new variants (Shackelton et
al., 2005). It is unknown how CPVevolves in cats. Since CPV is
a new pathogen for cats, it was hypothesized that host-specific
factors could accelerate the evolution of CPV, operating as a
driving force (Ikeda et al., 2002); our findings seem to confirm
this hypothesis. We reported on one domestic cat carrying
multiple strains of CPV with a variability detected in the VP2
region which ranged from 0.1 to 0.5 at the DNA level and from
0.2 to 0.7 at the protein level. In the same animal, we detected
co-infection with several CPV variants, type 2a and N/D426E.
Similar findings were detected also by Url et al. (2003) who
reported the coexistence of CPV-2 and FPV in one cat,
confirming that the infection of one animal with several
parvoviruses may occur; however, in our report, the genetic
complexity of 116_05 strain, with ten different viral clones, is
surprising. The simultaneous presence of multiple viral variants
in the same subject has already been reported for other
parvoviruses such as the AMDV (Gottschalck et al., 1991)
but has never been detected in vivo in CPV. A preceding study
regarding the evolution of CPV in vitro during viral attenuation
in tissue culture reported a high genetic heterogeneity in the
viral genome with 9 clones which have unique sequences at
passage 80 of the virus (Badgett et al., 2002). The authors
hypothesized that the cause of this extensive polymorphism
may be due to recombination events which have allowed the
simultaneous ascent of many mutations. Our analysis seems to
exclude the fact that recombination events happened during the
infection and it is possible that the animal was infected with
many variants simultaneously; subsequently, the high rates of
nucleotide substitution together with elevated population
growth allowed the adaptation and the appearance of CPV
variants detected in the animal.
Since new variants of CPV could persist in infected cats in
spite of the presence of the neutralizing antibodies (Ikeda et al.,
2002), it has been hypothesized that, also in our clinical case,
there was a persistent infection. A higher diversity in persistent
infection rather than in acute infection has also been observed for
other ssDNA viruses, and mixed infections by multiple variants
might also be an important multiplier of genetic diversity.
Analysis of selection pressure acting on the VP2 gene has
shown that a purifying selection is prevalent on the VP2 protein
and no sites are subject to positive selection. The major part of
25Rapid Communicationamino acid changes is situated on the inner surface of the capsid,
the most conserved region of the protein, while, for other
parvoviruses, a correlation between polymorphic residues and
their accessibility on the protein surface was observed (Martins
Soares et al., 2003). Therefore, these mutations are not a direct
result of immune selection but are probably the consequence of
the intrinsic high rate of mutation in CPV (Shackelton et al.,
2005). Furthermore, these residues are not implicated in
molecular interactions or biological functions of the viruses so
this region can accommodate high levels of non-synonymous
mutations without interfering with the fundamental function of
the protein.
In conclusion, these findings display the remarkable genetic
heterogeneity and evolutionary capacity of CPV-2 which
reassembles the quasispecies distribution found in the RNA
virus population. Furthermore, this is the first report of the
detection of multiple CPV variants in the same animal which
confirms how multiple infection can also occur for CPVas is the
case for other parvoviruses.
Materials and methods
The small intestine was removed from a domestic cat which
died exhibiting enteric symptomatology (reference number
116_05). A parvoviral infection was detected by an examination
of the intestinal contents using a parvoviral antigen detection kit
(SNAP PARVO, IDEEX).
The whole VP2 gene was amplified with the primers P1 (5′-
ATGAGTGATGGAGCAGTTC-3′) and VPR (5′-TTCT-
AGGTGCTAGTTGAG-3′) using the Klen Taq LA Polymerase
Mix (BD Biosciences, Clontech, USA) which contains Klen Taq-
1 DNA polymerase as the primary polymerase and a minor
amount of a 3′ → 5′ proofreading polymerase for high fidelity
PCR. Direct sequencing of PCR products showed an unusually
high number of ambiguities, although a proofreading Taq was
used; this result suggested mixed viral populations so the
amplification products of 1745 bp were cloned into the PCR 4/
TOPO vector using the TOPO cloning kit (Invitrogen, Nether-
lands) and were transformed into Escherichia coli DH5α-
competent cells according to the manufacturer's protocol.
Fourteen recombinant clones were purified with Turbo Kit
(QBIOgene, UK) and were sequenced using standard dideoxy
sequencing with fluorescence-labeled nucleotides (Perkin-Elmer
Applied Biosystem).
In order to determine how many substitutions were
associated with Taq DNA polymerase-induced error, the VP2
gene was amplified using a clone previously sequenced. The
resulting amplicon was sequenced directly and shown to be
100% identical to the sequence of the recombinant plasmid
(data not presented), suggesting that any contribution by Taq to
the observed substitution rates was low.
The nucleotide sequences obtained were compared to
sequences available from the GenBank using the CLUSTAL
W web interface (http://www.ebi.ac.uk/clustalw/). The degree
of similarity among the sequences at both the nucleotide and the
amino acid level was determined by the MEGALIGN program
(DNASTAR software package, Lasergene Inc., USA).A variety of statistical analyses regarding nucleotide
diversity and sequence variability were carried out on the
sequence data set using the versatile program DNASP version
4.10 (Rozas et al., 2003) which has a user-friendly interface.
The following parameters were considered: the number of
polymorphic sites S, the Watterson's parameter θw which
estimates the level of population variation on the basis of the
number of segregating sites in the sample, the mean pairwise
diversity Pi (π) calculated from the total number of sites and its
standard error and the average number of nucleotide differences
k. In the same statistical analysis of genetic diversity, an
additional sequence data set of Italian CPV-2 strains (n = 19)
was also computed (Battilani et al., 2002).
To examine the evolutionary pressures which contributed to
a genetic variation in the 116_05 strain, the ratio of non-
synonymous substitutions per non-synonymous site (dN) to
synonymous substitutions per synonymous site (dS) was
estimated using the Datamonkey web interface (http://www.
datamonkey.org), a maximum-likelihood-based tool for the
identification of sites subject to positive or negative selection.
Datamonkey uses three complementary methods: single like-
lihood ancestor counting (SLAC), fixed effects likelihood
(FEL) and random effects likelihood (REL).
Recombination was examined using the RDP2 package
(Martin et al., 2005) which permits the detection of recombina-
tion events using 10 published recombination detection
methods.
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